DL

Douglas Alan Livingston

LP La Jolla Pharmaceuticals: 11 patents #3 of 29Top 15%
GW Glaxo Wellcome: 5 patents #25 of 449Top 6%
TU The Upjohn: 4 patents #111 of 528Top 25%
SL Smithkline Beecham Limited: 3 patents #419 of 1,624Top 30%
📍 Kalamazoo, MI: #56 of 1,283 inventorsTop 5%
🗺 Michigan: #3,266 of 86,293 inventorsTop 4%
Overall (All Time): #186,267 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
7351855 Chemically defined non-polymeric valency platform molecules and conjugates thereof Stephen Coutts, David S. Jones, Lin Yu 2008-04-01
7115581 Chemically-defined non-polymeric valency platform molecules and conjugates thereof Stephen Coutts, David S. Jones, Lin Yu 2006-10-03
7002012 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-YI)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders Susan Mary Daluge, Gerald Wolberg 2006-02-21
6437124 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl) phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders Susan Mary Daluge, Gerald Wolberg 2002-08-20
6392085 Therapeutic nucleosides Susan Mary Daluge 2002-05-21
6355646 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl)phenyl derivatives, their preparation and their use in treatment of inflammatory conditions and immune disorders Susan Mary Daluge, Gerald Wolberg 2002-03-12
6166198 Methods for oligonucleotide synthesis 2000-12-26
5919941 Intermediates for the preparation of sulphonic acid salts of 4-amino-2-cyclopentene-1-carboxylic acid Susan Mary Daluge 1999-07-06
5874552 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides David S. Jones, John P. Hachmann, Michael J. Conrad, Stephen Coutts 1999-02-23
5856464 Selective capping solution phase oligonucleotide synthesis 1999-01-05
5840990 Intermediates to carbocyclic nucleosides Susan Mary Daluge 1998-11-24
5808147 Therapeutic nucleosides Susan Mary Daluge 1998-09-15
5786512 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides David S. Jones, John P. Hachmann, Michael J. Conrad, Stephen Coutts 1998-07-28
5726329 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides David S. Jones, John P. Hachmann, Michael J. Conrad, Stephen Coutts 1998-03-10
5641889 Therapeutic nucleosides Susan Mary Daluge 1997-06-24
5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof Stephen Coutts, David S. Jones, Lin Yu 1997-05-27
5606047 Chemically-defined non-polymeric valency platform molecules and conjugates thereof Stephen Coutts, David S. Jones, Lin Yu 1997-02-25
5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof Stephen Coutts, David S. Jones, Lin Yu 1996-09-03
5391785 Intermediates for providing functional groups on the 5' end of oligonucleotides David S. Jones, John P. Hachmann, Michael J. Conrad, Stephen Coutts 1995-02-21
4977255 Steroidal 17.alpha.-silyl ethers and process to corticoids and progesterones Bruce Allen Pearlman, Scott E. Denmark 1990-12-11
4921638 17.beta.-cyano-9.alpha.,17.alpha.-dihydroxyandrost-4-en-3-one Bruce Allen Pearlman, Scott E. Denmark, Joel E. Huber 1990-05-01
4710565 Thesis of 7-halo-7-deoxylincomycins Janet E. Petre 1987-12-01
4568741 Synthesis of 7-halo-7-deoxylincomycins 1986-02-04